Am J Transplant, Volume 16, Suppl 3 Archives - Page 106 of 180 - ATC Abstracts

2016 American Transplant Congress
Assessment of Molecular Mechanisms of Non-Transplant Cardiac Hypertrophy in Cardiac Allograft Hypertrophy – An Exploratory Gene Array Study of Myocardial Biopsy Samples.
R. Araujo-Gutiérrez,^1,2 S. Ibarra-Cortez,^1,2 M. Park,¹ J. Estep,¹ G. Ashrith,¹ B. Trachtenberg,¹ G. Torre-Amione,¹ K. Youker,^1,2 A. Bhimaraj.¹
¹Houston Methodist DeBakey Heart & Vascular Center, Houston, TX; ²Houston Methodist Research Institute, Houston, TX.
Cardiac Allograft Hypertrophy (CAH) develops in up to 80% of patients as early as six months post-transplant, and is associated with decreased quality of life…
2016 American Transplant Congress
Gene Expression Profiling Score and the Risk of Infection in Heart Transplant Recipients.
J. Teuteberg,¹ D. Budge,² M. Shullo,¹ S. Hall,³ J. Kobashigawa.⁴
¹University of Pittsburg, Pittsburgh, PA; ²Intermountain Medical Center, South Lake City, UT; ³Baylor University Medical Center, Dallas, TX; ⁴Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: This study assessed the association of gene expression profiling (GEP, AlloMap®) score with infections in heart transplant recipients (HTR). Although a GEP score below…
2016 American Transplant Congress
Prolonged Pre-Transplant Dialysis Duration Reverses the “Nephroprotective Effect” in Simultaneous Liver-Kidney Transplant Recipients.
M. Casey, X. Wen, A. Santos, S. Rehman, K. Womer.
University of Florida, Gainesville.
Past literature has suggested that simultaneous liver-kidney(SLK) transplant recipients may experience a nephroprotective effect compared to kidney(Ki) alone transplant recipients. Since hepatorenal syndrome is a…
2016 American Transplant Congress
High KDPI Is a Predictor of Acute Rejection in Delayed Graft Function.
B. Muth,¹ J. Turk,¹ S. Parajuli,¹ D. Mandelbrot,¹ M. Mohamed,¹ R. Redfield,² D. Kaufman,² A. Djamali.^1,2
¹Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI; ²Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, WI.
The kidney donor profile index (KDPI) is a prognostic measure for graft function and survival. It is unclear whether it predicts acute rejection in patients…
2016 American Transplant Congress
Dual Kidney Transplants as Policy to Optimize the Allocation of Marginal Donor Kidneys: Analysis of the French Cohort Since 2002.
E. Savoye,¹ R. Snanoudj,² C. Hiesse,³ M.-N. Peraldi,⁴ A. Durrbach,⁵ N. Ouali,⁶ M. Durand,⁷ L. Badet,⁸ M.-A. Macher.¹
¹Agence de la Biomédecine, Saint Denis, France; ²Necker hospital, Paris, France; ³Foch hospital, Suresnes, France; ⁴Saint Louis Hospital, Paris, France; ⁵Bicêtre Hospital, Kremlin Bicetre, France; ⁶Tenon hospital, Paris, France; ⁷Pasteur hospital Nice, Nice, France; ⁸Department of Chirurgie de la Transplantation Pav V and Department of Immunologie Clinique Transplantation Pav P, Edouard Herriot Hospital Group, Lyon, France.
The aim of this national multicentre cohort study was to assess the safety of dual kidney transplantation (DKT) in terms of patient and graft survival…
2016 American Transplant Congress
A Genome Wide Association Study of New Onset Diabetes After Transplant in Kidney Transplantation.
A. Giri,¹ M. Sanders,² D. Velez Edwards,¹ T. Ikizler,³ D. Roden,³ K. Birdwell.³
¹Epidemiology, Vanderbilt University Medical Center, Nashville, TN; ²Medicine, University of Iowa, Iowa City, IA; ³Medicine, Vanderbilt University Medical Center, Nashville, TN.
Purpose: New-onset diabetes after transplantation (NODAT) is associated increased mortality. Using a DNA biobank linked to electronic medical records (EMR) at Vanderbilt University (BioVU), we…
2016 American Transplant Congress
Liver Transplantation in Patients Actively Drinking Less Than 6 Months Before Transplant Presenting with Acute Decompensation: A Single-Center Experience.
H. Monsour, D. Victor, M. Boktour, J. Galati, J. Ontiveros, L. Theriot, R. McFadden, C. Mobley, A. Saharia, S. Gordon-Burroughs, A. Gaber, R. Ghobrial.
Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX.
Background: Alcohol is amongst the leading causes of liver disease worldwide. Most centers have a 6-month abstinence requirement before transplantation candidacy. Mortality rates for acute…
2016 American Transplant Congress
Resolution of Donor Non-Alcoholic Fatty Liver Disease Following Liver Transplantation.
A. Posner,¹ W. Twaddell,² S. Hanish,² D. Bruno,² W. Hutson,² L. Hebert,² R. Barth,² J. LaMattina.²
¹University of Maryland School of Medicine, Baltimore, MD; ²Division of Transplantation, University of Maryland School of Medicine, Baltimore, MD.
Purpose: Severe and moderate degrees of donor liver steatosis have traditionally limited the transplantation of these organs. The natural history of successfully transplanted livers with…
2016 American Transplant Congress
Effect of Early Tacrolimus Trough Variability on Graft Outcomes in Lung Transplantation.
K. Boyle, M. Moranville, P. Shah.
The Johns Hopkins Hospital, Baltimore, MD.
Background: Recent data suggests that variability in tacrolimus trough levels after lung transplant may be associated with poor long term graft outcomes. The purpose of…
2016 American Transplant Congress
Recipient Outcomes in U.S. Cases of Post-Donation Living Donor Malignancy.
A. Wilk,¹ S. Taranto,¹ M. Nalesnik.³
¹United Network for Organ Sharing, Richmond, VA; ²Duke Univ Medical Center, Durham, NC; ³Univ of Pittsburgh, Pittsburgh, PA.
Background: Under current OPTN policy, living donors (LD) are required to be followed for two years (yrs) post-donation. Cases of malignancy in LD post-donation can…